National and Kapodistrian University of Athens
Αξιολόγηση κυκλοφορούντων μικροσωματιδίων στη χρόνια ηπατίτιδα C σε ασθενείς υπό θεραπεία με ιντερφερόνη και ριβαμπιρίνη
Abstract
dc:descriptionPlatelet-microparticles/PMPs are platelet-derived membrane vesicles involved in atherosclerosis. We evaluated PMPs before and after treatment with pegylated-interferon-alfa+ribavirin in chronic hepatitis-C/CHC patients and patients with non-alcoholic-fatty-liver-disease/NAFLD and healthy volunteers/HV were used as controls. PMPs levels were determined at baseline in CHC-patients and controls as well as at the end-of-treatment/EOT and 24-weeks-post-treatment/SVR24 in CHC patients. PMPs levels at baseline were higher in CHC than NAFLD patients and HV. Higher PMPs at baseline were observed in smokers than non-smokers with CHC. Among smokers from all groups, PMPs at baseline were higher in CHC than NAFLD patients and HV. In CHC-patients, PMPs declined from baseline to both EOT and SVR24. Only CHC-patients with sustained-virological response/SVR had significant decline in PMPs from baseline to SVR24. PMPs at ΕΟΤ and SVR24 in all CHC patients were similar to PMPs in control groups. PMPs levels are increased in CHC-patients, particularly smokers, which further support the atherosclerotic potential of CHC and suggest a potentially synergistic effect of smoking and CHC on the atherosclerotic process. Since PMPs levels in CHC-patients with SVR do not differ from those in controls, the atherosclerotic potential of CHC seems to be abolished by effective antiviral treatment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kanellopoulou, Theoni
- Κανελλοπούλου, Θεώνη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/37474